Finger-prick test could make type 1 diabetes screening child's play

NCT ID NCT06984185

Recruiting now Diagnosis Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a combined autoantibody test on a drop of blood from a finger prick (dried on special paper) can detect type 1 diabetes as accurately as the standard blood draw from a vein. The researchers will enroll 106 children newly diagnosed with type 1 diabetes. If the finger-prick test works well, it could pave the way for easier, at-home screening for children at risk of developing the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: combined autoantibody test (3 Screen) and immunoreactive trypsin assay on blotting paper
What this could lead to: If validated, this simple finger-prick test could make early screening for type 1 diabetes much easier and more accessible, especially for children at risk.
What could go wrong: This is a small validation study in children already diagnosed with diabetes, not a large screening trial. The test may not perform as well in real-world, pre-symptomatic screening.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Femme Mère Enfant Hospital, Hospices Civils de Lyon
RECRUITING

Bron, Rhône, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.